Oral Hormone Replacement Therapy Linked to Increased Risk of Blood Clots
Audio narration · Coming soon
A large Danish study published in The BMJ finds that current use of oral menopausal hormone therapy is associated with an increased risk of venous thromboembolism, including blood clots in the legs and lungs. This risk appears regardless of the hormone dose or duration of treatment.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews
